#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatoblastoma Hodgkin's disease refractory Gastroenteropancreatic neuroendocrine tumour disease Dilated cardiomyopathy Cortical dysplasia Oropharyngeal cancer recurrent Emphysema Basal cell naevus syndrome Congenital absence of bile ducts Follicle centre lymphoma follicular grade I, II – III Leukocyte adhesion deficiency Ataxia telangiectasia Thalassaemia Small intestine leiomyosarcoma Cerebral arteriovenous malformation haemorrhagic More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis – Trials in Disease Prolymphocytic leukaemia – Basic Information Angiosarcoma non-metastatic – Trials in Disease Glycogen storage disease type I – Diagnostics Primary mediastinal large B-cell lymphoma – Treatment Pemphigus – Life with Disease Waldenstrom’s macroglobulinaemia recurrent Cerebral arteriovenous malformation haemorrhagic – Basic Information Thrombotic thrombocytopenic purpura – Basic Information Ehlers-Danlos syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Coffee Charcoal Nomegestrol Acetate Cefotaxime Cannabis Sativa Flower Ontasameran Sodium Glycocholate ANTI-GD2-800CW YL201 TUB-030 Lumasiran Regtivex Celecoxib Insulin Icodec Terlipressin F1245/05 Gemlapodect Clarithromycin Lysine Aspirin Iptacopan Hydrochloride Ag-946 More therapies…

    Learn about Your Condition

    Brain cancer metastatic Mastocytosis Pulmonary resection Adenocarcinoma Oropharyngeal cancer recurrent Immunosuppression Neuroblastoma Wolfram syndrome Bone marrow failure Dysmenorrhoea Atopic keratoconjunctivitis Endometrial cancer stage II Tertiary adrenal insufficiency Benign neoplasm of ureter Erythema migrans More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mssjch Zmgxwrsj Kvofq 2hv Dwiylcawi 4ogrn Hbvjktc

Want to learn more about this study or check if you can participate? Contact us.

  • A study testing fitusiran to prevent bleeding in boys aged 1 to 11 years with hemophilia A or B with or without inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Haemophilia
    Investigated Drugs:
    • Fitusiran
    Belgium Germany Hungary Italy Poland Romania +1

  • A study testing vipoglanstat for women with moderate to severe endometriosis-related pain

    Recruiting

    2 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • GS-248
    • VIPOGLANSTAT
    Bulgaria Czechia Hungary Italy Poland Romania

  • A study comparing 4D-150 and aflibercept for adults with abnormal blood vessel growth in the eye due to age-related macular degeneration

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • ZUNIBERGENE ROCPARVOVEC
    • Aflibercept
    Bulgaria France Germany Hungary Italy Latvia +3

  • A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

    Recruiting

    3 1 1
    Investigated Drugs:
    • Depemokimab
    • Salbutamol Sulfate
    Belgium Croatia Denmark France Germany Hungary +8

  • A study testing intranasal esketamine compared to midazolam for rapidly reducing symptoms of major depressive disorder in adolescents with suicidal thoughts or behavior

    Recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Midazolam
    • Esketamine
    Hungary Italy Romania Spain

  • A Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Azd8205
    • Doxorubicin
    • Paclitaxel
    Austria Belgium Czechia Denmark Finland France +9

  • A Study Testing Casdatifan and Cabozantinib Compared to Placebo and Cabozantinib in Patients With Advanced Clear Cell Kidney Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Clear cell renal cell carcinoma
    Investigated Drugs:
    • AB521
    • Cabozantinib
    • Placebo
    Czechia France Germany Hungary Italy The Netherlands +3

  • A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Saruparib
    • Abiraterone Acetate
    Austria Belgium Finland France Germany Hungary +5

  • A study to test how well empagliflozin works and how safe it is for children and teenagers with chronic kidney disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Empagliflozin
    Belgium France Germany Hungary Italy The Netherlands +4

  • A study testing xanomeline tartrate and trospium chloride for treating agitation in patients with Alzheimer’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Czechia France Hungary Italy Poland
Previous Page
1 … 5 6 7 8 9 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!